For example, Smad3 mRNA could be modified by METTL3-mediated m6A, which was subsequently recognized and stabilized by IGF2BP2, thereby enhancing Smad3 protein expression and promoting the activation of TGF-β/Smad pathway in GC to promote proliferation and metastasis (33). The gene discussed is IGF2BP2; the disease is gastric cancer.